Diabetes and its cardiometabolic complications are growing rapidly, and creating overwhelming public health and economic burdens in the USA and worldwide. Innovative research is necessary to curb this pandemic, which will require the training of new generations of multidisciplinary investigators. The proposed University of Maryland T32 training program in Diabetes and Its Metabolic Complications (DMC) will fulfill an unmet need for research training specifically focused on genomic approaches to diabetes from discovery to implementation into patient care. We request support for 2 pre- and 2 post-doctoral (PhD, MD or MD/PhD) fellows annually for 5 years to create a cadre of future leaders in diabetes translational genomics research. Our T32 curriculum focuses on three mutually informative research tracks to advance genomic discoveries to new mechanistic understandings to novel approaches for treatment and prevention of diabetes and its metabolic complications: 1) Genetics/genomics; 2) Pathophysiology of diabetes, metabolic syndrome, obesity, and their cardiovascular complications; and 3) Therapeutic strategies. Didactics will be required to fulfill core competencies in one of the three tracks; however the curriculum will provide sufficient flexibility to individualize to the specific interests and needs of each trainee. DMC trainees will be immersed in an intensive, comprehensive, mentored research experience. Our 16 DMC Training Grant faculty are experienced mentors, independent well-funded and productive investigators who work together in multidisciplinary teams that span genetics/genomics, molecular, cellular, and pathophysiological mechanisms of disease, translational research, and patient- and population-oriented research. The research environment and resources available to trainees in diabetes translational genomics research at the University of Maryland are substantial and include the NIH-funded Mid-Atlantic Nutrition Obesity Research Center (NORC) and the Baltimore Diabetes Research Center (DRC). One of the signature programs of DMC faculty is the Amish Genomics Research Program, which provides unprecedented opportunities for training and research in diabetes translational genomics. The DMC Training Program will be directed by Drs. Alan Shuldiner and Michael Quon. Implementation/development of our program including curriculum development, trainee selection from a large pool of highly qualified applicants, mentor pairing, tracking/guidance of trainees/mentors, and evaluation of the Training Program will be overseen by a Steering Committee, with programmatic oversight by Internal and External Advisory Committees. The DMC T32 Training Program will enable senior accomplished University of Maryland faculty to train, mentor, and nurture exceptional pre- and post-doctoral fellows for success in independent scholarly careers in biomedical research focused on diabetes translational genomics. Such training is essential for effectively addressing enormous public health/economic costs associated with diabetes and its metabolic complications.

Public Health Relevance

Diabetes and its complications are growing rapidly, and exacting a huge public health and economic burden. Innovative research, which will require training of new generations of multidisciplinary investigators, is necessary to curb this pandemic. The proposed University of Maryland T32 training program in Diabetes and Its Metabolic Complications (DMC) will fulfill an unmet need for research training specifically focused on genomic approaches to translational diabetes research. This approach will expand mechanistic understanding at the molecular, cellular and pathophysiological levels, and enable translational research to improve our ability to treat and prevent this devastating disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK098107-02
Application #
9091497
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK)
Program Officer
Castle, Arthur
Project Start
2015-07-01
Project End
2018-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Rao, Xiaoquan; Zhong, Jixin; Brook, Robert D et al. (2018) Effect of Particulate Matter Air Pollution on Cardiovascular Oxidative Stress Pathways. Antioxid Redox Signal 28:797-818
Hostelley, Timothy L; Nesmith, Jessica E; Zaghloul, Norann A (2017) Sample Preparation and Analysis of RNASeq-based Gene Expression Data from Zebrafish. J Vis Exp :
Xia, Chang; Goud, Aditya; D'Souza, Jason et al. (2017) DPP4 inhibitors and cardiovascular outcomes: safety on heart failure. Heart Fail Rev 22:299-304
Winters, Alexandra; Ramos-Molina, Bruno; Jarvela, Timothy S et al. (2017) Functional analysis of PCSK2 coding variants: A founder effect in the Old Order Amish population. Diabetes Res Clin Pract 131:82-90
Xia, Chang; Rao, Xiaoquan; Zhong, Jixin (2017) Role of T Lymphocytes in Type 2 Diabetes and Diabetes-Associated Inflammation. J Diabetes Res 2017:6494795
Kleinberger, Jeffrey W; Maloney, Kristin A; Pollin, Toni I (2016) The Genetic Architecture of Diabetes in Pregnancy: Implications for Clinical Practice. Am J Perinatol 33:1319-1326
Lodh, Sukanya; Hostelley, Timothy L; Leitch, Carmen C et al. (2016) Differential effects on ?-cell mass by disruption of Bardet-Biedl syndrome or Alstrom syndrome genes. Hum Mol Genet 25:57-68
Zhong, Jixin; Allen, Katryn; Rao, Xiaoquan et al. (2016) Repeated ozone exposure exacerbates insulin resistance and activates innate immune response in genetically susceptible mice. Inhal Toxicol 28:383-92
Jarvela, Timothy S; Lam, Hoa A; Helwig, Michael et al. (2016) The neural chaperone proSAAS blocks ?-synuclein fibrillation and neurotoxicity. Proc Natl Acad Sci U S A 113:E4708-15
Brook, Robert D; Sun, Zhichao; Brook, Jeffrey R et al. (2016) Extreme Air Pollution Conditions Adversely Affect Blood Pressure and Insulin Resistance: The Air Pollution and Cardiometabolic Disease Study. Hypertension 67:77-85

Showing the most recent 10 out of 16 publications